BIXT
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
12.17M
TTNP
Price
$4.65
Change
-$0.26 (-5.30%)
Updated
Jun 6 closing price
Capitalization
4.49M
Interact to see
Advertisement

BIXT vs TTNP

Header iconBIXT vs TTNP Comparison
Open Charts BIXT vs TTNPBanner chart's image
Bioxytran
Price$0.14
Change-$0.00 (-0.00%)
Volume$96.07K
Capitalization12.17M
Titan Pharmaceuticals
Price$4.65
Change-$0.26 (-5.30%)
Volume$77.7K
Capitalization4.49M
BIXT vs TTNP Comparison Chart
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. TTNP commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a StrongBuy and TTNP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BIXT: $0.16 vs. TTNP: $4.62)
Brand notoriety: BIXT and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 42% vs. TTNP: 44%
Market capitalization -- BIXT: $12.17M vs. TTNP: $4.49M
BIXT [@Biotechnology] is valued at $12.17M. TTNP’s [@Biotechnology] market capitalization is $4.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIXT and TTNP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 6 TA indicator(s) are bullish while TTNP’s TA Score has 6 bullish TA indicator(s).

  • BIXT’s TA Score: 6 bullish, 4 bearish.
  • TTNP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BIXT and TTNP are a good buy in the short-term.

Price Growth

BIXT (@Biotechnology) experienced а +13.25% price change this week, while TTNP (@Biotechnology) price change was +2.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIXT($12.2M) has a higher market cap than TTNP($4.49M). BIXT YTD gains are higher at: 76.863 vs. TTNP (41.718). BIXT has higher annual earnings (EBITDA): -2.67M vs. TTNP (-4.55M). TTNP has more cash in the bank: 2.83M vs. BIXT (34.7K). TTNP has less debt than BIXT: TTNP (0) vs BIXT (934K). BIXT (0) and TTNP (0) have equivalent revenues.
BIXTTTNPBIXT / TTNP
Capitalization12.2M4.49M272%
EBITDA-2.67M-4.55M59%
Gain YTD76.86341.718184%
P/E RatioN/AN/A-
Revenue00-
Total Cash34.7K2.83M1%
Total Debt934K0-
FUNDAMENTALS RATINGS
BIXT vs TTNP: Fundamental Ratings
BIXT
TTNP
OUTLOOK RATING
1..100
1711
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3742
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (85) in the null industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that BIXT’s stock grew similarly to TTNP’s over the last 12 months.

BIXT's Profit vs Risk Rating (100) in the null industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that BIXT’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as BIXT (100) in the null industry. This means that TTNP’s stock grew similarly to BIXT’s over the last 12 months.

BIXT's Price Growth Rating (37) in the null industry is in the same range as TTNP (42) in the Pharmaceuticals Major industry. This means that BIXT’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's P/E Growth Rating (75) in the Pharmaceuticals Major industry is in the same range as BIXT (100) in the null industry. This means that TTNP’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTTTNP
RSI
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
80%
MACD
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 12 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
79%
Bullish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+1.21%
CING - BIXT
26%
Poorly correlated
+8.99%
CYTK - BIXT
22%
Poorly correlated
-0.82%
APLM - BIXT
21%
Poorly correlated
+1.14%
ANEB - BIXT
20%
Poorly correlated
-4.42%
TTNP - BIXT
20%
Poorly correlated
-0.65%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
-0.65%
INM - TTNP
43%
Loosely correlated
-5.40%
BPMUF - TTNP
27%
Poorly correlated
N/A
CYTK - TTNP
23%
Poorly correlated
-0.82%
SER - TTNP
22%
Poorly correlated
-2.78%
SPHRY - TTNP
22%
Poorly correlated
N/A
More